Pople I K, Muhlbauer M S, Sanford R A, Kirk E
University of Tennessee, Le Bonheur Children's Medical Center, Nashville, USA.
Pediatr Neurosurg. 1995;23(2):64-7. doi: 10.1159/000120938.
303 consecutive children who had insertion of an intracranial pressure (ICP) monitor for various reasons were reviewed to determine clinical value and complications rate of ICP monitoring in this age group. 286 patients had a Camino fiberoptic monitor. Of the remaining cases, 9 had a ventricular catheter, 7 had an extradural Gaeltec monitor, and 1 had a subdural feeding tube. The reasons for monitoring the ICP were: trauma in 132 children, postoperative monitoring after tumor surgery in 91, head injury due to child abuse in 30, severe medical conditions such as meningitis, encephalitis, and near-drowning in 30, intracranial hemorrhage in 15, and hydrocephalus in 5 children. The median age at insertion was 6 years (range from 1 month to 17 years), and the median Glasgow coma score before insertion was 7. Median duration of monitoring was 3 days, and 35 children (10%) had surgical procedures performed for raised ICP detected by monitoring. 238 (78%) had nonsurgical measures to control raised ICP. 6 (15%) of 40 children with an initial ICP > 50 mm Hg made a good recovery, but there were no survivors among 37 children who had an ICP consistently > 60 mm Hg and only 1 disabled survivor among 42 children with an ICP consistently > 50 mm Hg. The outcome in all 303 children correlated with averaged readings of ICP over 24 h and initial Glasgow coma score, but did not correlate with initial ICP measurements. Complications of monitoring were few and consisted of infection in 1 (0.3%) child, intracranial hemorrhage in 1 (0.3%) who had low platelet counts, displacement of monitor in 3 (1%), and malfunction of monitor in 8 (2.6%) children. We conclude that ICP monitoring in the pediatric age group substantially influences our clinical management of unconscious children and is safe.
对303例因各种原因植入颅内压(ICP)监测器的连续儿童进行了回顾性研究,以确定该年龄组ICP监测的临床价值和并发症发生率。286例患者使用了Camino光纤监测器。其余病例中,9例使用了脑室导管,7例使用了硬膜外Gaeltec监测器,1例使用了硬膜下饲管。监测ICP的原因如下:132例儿童因外伤,91例因肿瘤手术后进行术后监测,30例因虐待儿童导致头部受伤,30例因严重疾病如脑膜炎、脑炎和近乎溺水,15例因颅内出血,5例因脑积水。植入时的中位年龄为6岁(范围为1个月至17岁),植入前的中位格拉斯哥昏迷评分为7分。中位监测持续时间为3天,35例儿童(10%)因监测发现ICP升高而接受了手术治疗。238例(78%)采取了非手术措施来控制ICP升高。40例初始ICP>50 mmHg的儿童中有6例(15%)恢复良好,但37例ICP持续>60 mmHg的儿童无幸存者,42例ICP持续>50 mmHg的儿童中仅有1例残疾幸存者。所有303例儿童的预后与24小时内ICP的平均读数和初始格拉斯哥昏迷评分相关,但与初始ICP测量值无关。监测的并发症很少,包括1例(0.3%)儿童感染,1例(0.3%)血小板计数低的儿童发生颅内出血,3例(1%)监测器移位,8例(2.6%)儿童监测器故障。我们得出结论,儿童年龄组的ICP监测对我们对昏迷儿童的临床管理有重大影响且是安全的。